Formulaciones de liposomas multivesiculares de ácido tranexámico

Composición farmacéutica que comprende: liposomas multivesiculares que encapsulan ácido tranexámico, comprendiendo dichos liposomas multivesiculares: ácido tranexámico, un componente lipídico que comprende por lo menos un lípido anfipático y por lo menos un lípido neutro, y uno o más agentes modificadores del pH. Some embodiments of the present application are related to multivesicular liposome formulations comprising tranexamic acid (TXA) for the purpose of minimizing the side effects of unencapsulated tranexamic while maintaining or improving efficacy and lengthening the duration of the effect. Methods of making and administering the tranexamic acid encapsulated multivesicular liposome formulations and their use as medicaments are also provided.